Differentially expressed genes in PPARg-deficient MSCs

被引:6
作者
Su, Yun [1 ]
Shen, Xiaona [2 ]
Chen, Jie [3 ]
Isales, Carlos M. [1 ,4 ]
Zhao, Jing [2 ]
Shi, Xing-Ming [1 ,4 ]
机构
[1] Dept Neurosci & Regenerat Med, Augusta, GA USA
[2] Logist Engn Univ, Dept Math, Chongqing, Peoples R China
[3] Augusta Univ, Dept Biostat & Epidemiol, Augusta, GA USA
[4] Augusta Univ, Orthopaed Surg, Augusta, GA 30912 USA
基金
美国国家卫生研究院;
关键词
RNA-Seq; Differential expression; PPAR gamma; Inflammation; MSC; Adipocyte; Bone marrow; ACTIVATED-RECEPTOR-GAMMA; MESENCHYMAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; MARROW STROMAL CELLS; BONE-MARROW; LIPOPROTEIN-LIPASE; ADIPOSE-TISSUE; INSULIN-RESISTANCE; DISEASE; INFLAMMATION;
D O I
10.1016/j.mce.2017.07.037
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a key regulator of adipogenesis. It is also a central player in energy metabolism, inflammation and immunity. As an important nuclear transcription factor, PPAR gamma can regulate the expression and function of genes or biological processes directly or indirectly via association with other factors and thus modulate their activities. To better understand the impact of PPAR gamma on the global gene expression profile, we evaluated the bioinformatic data, which revealed the changes that occurred in genes and their pathways in the absence of PPAR gamma. In brief, we performed RNA deep sequencing (RNA-Seq) analysis using RNA samples isolated from multipotent mesenchymal stromal cells (MSCs) of PPAR gamma knockout and wild type control mice. The RNA-Seq data sets were then subjected to bioinformatic analyses from various angles to better reveal the breadth of PPAR gamma function in different biological processes. Our results reveal novel genes and networks modulated by PPAR gamma and provides new insights into our understanding of the physiologic and pathophysiologic role this nuclear receptor plays in health and disease. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 74 条
  • [1] Tumor necrosis factor-α inhibits pre-osteoblast differentiation through its type-1 receptor
    Abbas, S
    Zhang, YH
    Clohisy, JC
    Abu-Amer, Y
    [J]. CYTOKINE, 2003, 22 (1-2) : 33 - 41
  • [2] Cytokines and bone loss in a 5-year longitudinal study - Hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The Danish Osteoporosis Prevention Study
    Abrahamsen, B
    Bonnevie-Nielsen, V
    Ebbesen, EN
    Gram, J
    Beck-Nielsen, H
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (08) : 1545 - 1554
  • [3] Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux
    Akiyama, TE
    Sakai, S
    Lambert, G
    Nicol, CJ
    Matsusue, K
    Pimprale, S
    Lee, YH
    Ricote, M
    Glass, CK
    Brewer, HB
    Gonzalez, FJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (08) : 2607 - 2619
  • [4] PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors
    Akune, T
    Ohba, S
    Kamekura, S
    Yamaguchi, M
    Chung, UI
    Kubota, N
    Terauchi, Y
    Harada, Y
    Azuma, Y
    Nakamura, K
    Kadowaki, T
    Kawaguchi, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (06) : 846 - 855
  • [5] Increased Lipid Oxidation Causes Oxidative Stress, Increased Peroxisome Proliferator-activated Receptor-γ Expression, and Diminished Pro-osteogenic Wnt Signaling in the Skeleton
    Almeida, Maria
    Ambrogini, Elena
    Han, Li
    Manolagas, Stavros C.
    Jilka, Robert L.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (40) : 27438 - 27448
  • [6] Effects of chronic administration of PPAR-γ ligand rosiglitazone in Cushing's disease
    Ambrosi, B
    Dall'Asta, C
    Cannavò, S
    Libé, R
    Vigo, T
    Epaminonda, P
    Chiodini, L
    Ferrero, S
    Trimarchi, F
    Arosio, M
    Beck-Peccoz, P
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 (02) : 173 - 178
  • [7] PPARγ in Inflammatory Bowel Disease
    Annese, Vito
    Rogai, Francesca
    Settesoldi, Alessia
    Bagnoli, Siro
    [J]. PPAR RESEARCH, 2012, 2012
  • [8] PPARγ is required for placental, cardiac, and adipose tissue development
    Barak, Y
    Nelson, MC
    Ong, ES
    Jones, YZ
    Ruiz-Lozano, P
    Chien, KR
    Koder, A
    Evans, RM
    [J]. MOLECULAR CELL, 1999, 4 (04) : 585 - 595
  • [9] Discovering relationships between nuclear receptor signaling pathways, genes, and tissues in Transcriptomine
    Becnel, Lauren B.
    Ochsner, Scott A.
    Darlington, Yolanda F.
    McOwiti, Apollo
    Kankanamge, Wasula H.
    Dehart, Michael
    Naumov, Alexey
    McKenna, Neil J.
    [J]. SCIENCE SIGNALING, 2017, 10 (476)
  • [10] Treatment of active psoriatic arthritis with the PPARγ ligand pioglitazone:: an open-label pilot study
    Bongartz, T
    Coras, B
    Vogt, T
    Schölmerich, J
    Müller-Ladner, U
    [J]. RHEUMATOLOGY, 2005, 44 (01) : 126 - 129